SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego device maker ResMed Inc. reported a sizeable jump in revenue both for the company’s fourth quarter and its full 2016 fiscal year.
Medical device maker NuVasive Inc. reported a significant boost to the company’s sales and revenue for the second quarter, topping Wall Street’s expectations.
San Diego’s Sequenom Inc. is being acquired by LabCorp, a giant in the diagnostics and lab testing industry, in a deal worth $371 million.
San Diego’s medtech giant Illumina Inc. reported Tuesday that its second quarter revenue rose 11 percent.
Organovo Holdings Inc., the San Diego firm that “bioprints” three-dimensional human tissue, is moving its stock to the biotech-heavy Nasdaq exchange from the NYSE MKT.
San Diego biopharma Apricus Biosciences is expanding its exclusive distribution deal with Swiss firm Ferring Pharmaceuticals Inc. and terminating its deal with German drugmaker Sandoz.
Pharmaceutical giant Allergan Plc is backing out of its deal with San Diego-based Adamis Pharmceuticals Corp. to commercialize the firm’s epinephrine pre-filled syringe for the treatment of life-threatening allergic reactions (anaphylaxis).
Local digital health company AristaMD raised $11 million in a Series A financing, the company announced Friday.
The University of California, San Diego is opening an office in downtown Tokyo, where researchers will seek partnerships with Japan’s booming life science industry.
San Diego’s SpectraScience Inc., a medical device company using light technologies to detect and diagnose cancers, has signed a distribution agreement with Advanced Medical German Co. (AMG) in Kuwait to be its exclusive distributor in the Middle East.
Carlsbad drugmaker Ionis Pharmaceuticals Inc. has earned $10 million from Janssen Biotech Inc. by licensing out its gastrointestinal (GI) drug candidate, IONIS-JBI1-2.5Rx.
Gene sequencing giant Illumina Inc. is calling for startups to apply to its business accelerator program for early-stage businesses in the genomics space.
San Diego molecular information firm AltheaDx Inc. has raised $2.2 million in debt financing, according to a form recently filed with the Securities and Exchange Commission.
Leaders in San Diego’s genomics industry will address challenges and ideas in the precision medicine space at a local conference in August.
Arena Pharmaceuticals’ weight-loss drug, Belviq, has been approved for commercialization in Mexico, gaining Arena a milestone payment of $1 million.